Andrew John Phillips

Director · 3 filings · Latest: Aug 7, 2026

MoonLake Immunotherapeutics

OnKure Therapeutics, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
ELVN	ANDREW PHILLIPS	—	Mar 31, 2026	Proposed Sale	$38.55	26,035	$1.0M	—	Mar 31 8:26 PM
ELVN	ANDREW PHILLIPS	—	Feb 2, 2026	Proposed Sale	$28.00	21,844	$611.7K	—	Feb 2 10:38 PM